Sector: Pharmaceuticals & Biotechnology

Small Cap

Nectar Lifesciences Share Price

Q: What is the current share price of Nectar Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Nectar Lifesciences Ltd. is ₹ 12.03 on the NSE and ₹ 12.28 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Nectar Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Nectar Lifesciences Ltd. is approximately ₹ 272.5 Cr.

Q: What are the PE and PB ratios for Nectar Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Nectar Lifesciences Ltd. is -0.8, and the Price-to-Book (PB) ratio is 0.4.

Q: What is the 52-Week High and Low for Nectar Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Nectar Lifesciences Ltd. shares was ₹ 28.25, and the lowest price was ₹ 9.3.

Q: Who are the major shareholders of Nectar Lifesciences Ltd.?

Significant shareholdings in Nectar Lifesciences Ltd. typically include entities such as: Promoter Public Other Institutions FII (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Nectar Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Nectar Lifesciences Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Q: What is the latest dividend information for Nectar Lifesciences Ltd.?

Nectar Lifesciences Ltd. last declared a FINAL dividend of ₹ 0.05 per share for the financial period ending 2020. The record date was set as 2020-09-11, and the payment was/is scheduled around 2020-09-11. For the most current dividend announcements, refer to official company filings.

Q: What is the shareholding pattern for Nectar Lifesciences Ltd.?

As per the filings for the quarter ending Mar 2026, the approximate shareholding pattern for Nectar Lifesciences Ltd. is: Promoters: 51.8% Domestic Institutional Investors (DII): 4% Foreign Institutional Investors (FII): 0.6% Others (including Public): 0.1%

Nectar Lifesciences Ltd.

₹12.03

-0.03(-0.25%)

Trade Now

25th May 2026 | 3:28 PM

NSE : NECLIFE

Open Free Demat Account

Nectar Lifesciences Performance

Price Movement

₹12.03

₹12.61

↘ Today's Low↗ Today's High

1 Year Performance

₹12.03

₹9.30

₹28.25

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹12.61

Low₹12.03

Open at₹12.06

Prev Close₹12.06

Volumes2.41 L

Avg Price₹12.35

Lower Circuit₹11.46

Upper Circuit₹12.66

Historical Performance

3M High₹14.91

3M Low₹9.30

1 Yr High₹28.25

1 Yr Low₹9.30

3 Yr High₹56.50

3 Yr Low₹9.30

5 Yr High₹56.50

5 Yr Low₹9.30

Nectar Lifesciences Fundamentals

Market Cap

Below industry Median

272.50 Cr.

PE Ratio (TTM)

Negative PE TTM

-0.80

Dividend Yield

Net Profit TTM

2189% decr over last year

-355.06

Net Profit Growth

2189% decr over last year

-355.06

PEG Ratio

Below industry Median

ROE

2683% decr over last year

-11.88

Operating Revenue TTM

716.36

Operating Revenue Growth

57% decr over last year

Book Value

Low in industry

0.40

MFI

MFI is mid-range

67.81

RSI

RSI is mid-range

45.50

EPS (TTM)

-5.07

Debt to Equity

0.61

Face Value

Operating Profit Margin Qtr.

-1.76

Operating Profit Qtr.

-1.92

Net Profit Qtr.

14.27

Operating Revenue Qtr.

PB Ratio

0.40

Nectar Lifesciences Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	0	5	280.67	430.69	454.98
Operating Expense	1.92	6.04	342.56	585	410.27
Operating Profit	-1.92	-1.04	-61.89	-154.30	44.71
Depreciation	0.06	0.20	16.52	15.77	15.61
Interest	30.22	0	18.70	17.67	17.12
Tax	-11.02	-0.18	-33.52	-57.58	4.71
Net Profit	14.27	-176.01	-63.23	-130.09	7.84

Nectar Lifesciences Technicals

Nectar Lifesciences Ltd. EMA & SMA

₹12.03

-0.03 (-0.25%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹12.3

Day EMA10 ₹12.5

Day EMA12 ₹12.5

Day EMA20 ₹12.4

Day EMA26 ₹12.4

Day EMA50 ₹12.4

Day EMA100 ₹13.2

Day EMA200 ₹15.6

Nectar Lifesciences Support and Resistance

Resistance

First Resistance₹12.28

Second Resistance₹12.50

Third Resistance₹12.64

Support

First Support₹11.92

Second Support₹11.78

Third Support₹11.56

Technical Indicators

Day RSI45.50

Day MFI67.81

Day ADX29.04

Day Commodity Channel Index-80.40

William-90.76

Day MACD0.10

Day MACD Signal Line0.25

Day ATR0.63

Day ROC125-12.04

Day ROC21-1.31

Nectar Lifesciences Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	44.5	44.5	44.5	44.9	44.9	51.8
FII	0.7	1.6	0.8	0.6	0.5	0.6
DII	0.1	0.2	0.2	0.1	5.9	4
Public	54.7	53.6	54.4	54.4	48.7	43.5

Nectar Lifesciences Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.69 L	1.69 L	100.00%
Week	1.61 L	1.61 L	100.00%
1 Month	3.15 L	4.33 L	72.72%
6 Month	9.63 L	16.07 L	59.91%

Nectar Lifesciences SWOT Analysis

Strengths9

Weakness8

Opportunity1

Threats0

Promoter holding increased more than 2% QoQ

PEG lower than Industry PEG

Turnaround companies- loss to profit QoQ

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

High Volume, High Gain

Top Gainers

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Volume Shockers

Nectar Lifesciences Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
11 Sep, 2020	0.05	FINAL	Equity Share
19 Sep, 2019	0.05	FINAL	Equity Share
19 Sep, 2018	0.05	FINAL	Equity Share
20 Sep, 2017	0.05	FINAL	Equity Share
22 Sep, 2016	0.1	FINAL	Equity Share
22 Sep, 2015	0.1	FINAL	Equity Share
21 Aug, 2014	0.1	FINAL	Equity Share
19 Sep, 2013	0.1	FINAL	Equity Share
20 Sep, 2012	0.1	FINAL	Equity Share
21 Sep, 2011	0.1	FINAL	Equity Share

Nectar Lifesciences Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Innova Captab Ltd.
Price (₹)	₹492.90	₹6.40	₹131.01	₹13.79	₹559.75	₹852.80
% Change	1.27%	-2.14%	0.71%	-0.86%	0.46%	0.53%
Revenue TTM (₹ Cr)	-	₹83.60	₹287.68	-	₹502.55	₹1,630.02
Net Profit TTM (₹ Cr)	-	₹-34.95	₹14.88	-	₹57.92	₹140.92
PE TTM	-	-1.50	34.50	-	28.10	34.70
1 Year Return	24.95	544	4.98	51.43	-21.64	-3.98
ROCE	3.56	-5.63	-	-	23.87	15.27

Similar Stocks

VALIANTLAB

Valiant Laboratories Ltd.

₹ 78.00

+1.46%

SIGACHI

Sigachi Industries Ltd.

₹ 20.34

-0.05%

WINDLAS

Windlas Biotech Ltd.

₹ 784.40

-0.70%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

-1.69%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 556.00

+1.44%

ZIMLAB

Zim Laboratories Ltd.

₹ 99.45

-0.71%

MEDICO

Medico Remedies Ltd.

₹ 48.93

+2.28%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 198.45

+1.58%

LASA

Lasa Supergenerics Ltd.

₹ 8.07

+1.00%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 376.50

+0.36%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 302.20

-1.10%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.06

BROOKS

Brooks Laboratories Ltd.

₹ 56.41

+4.99%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2243.00

-2.22%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 135.50

+0.35%

ALPA

Alpa Laboratories Ltd.

₹ 67.85

-1.89%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 371.45

-2.62%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 29.01

-1.36%

INDOCO

Indoco Remedies Ltd.

₹ 195.70

-1.70%

INDSWFTLAB

Ind-Swift Laboratories Ltd.

₹ 133.00

+0.92%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 722.00

-1.65%

PANACEABIO

Panacea Biotec Ltd.

₹ 419.90

+0.32%

MEDICAMEQ

Medicamen Biotech Ltd.

₹ 268.35

-0.45%

FAQ's on NECLIFE

What is the current share price of Nectar Lifesciences Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Nectar Lifesciences Ltd. is ₹ 12.03 on the NSE and ₹ 12.28 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Nectar Lifesciences Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Nectar Lifesciences Ltd. is approximately ₹ 272.5 Cr.

What are the PE and PB ratios for Nectar Lifesciences Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Nectar Lifesciences Ltd. is -0.8, and the Price-to-Book (PB) ratio is 0.4.

What is the 52-Week High and Low for Nectar Lifesciences Ltd.?

Over the past 52 weeks, the highest price reached by Nectar Lifesciences Ltd. shares was ₹ 28.25, and the lowest price was ₹ 9.3.

Who are the major shareholders of Nectar Lifesciences Ltd.?

Significant shareholdings in Nectar Lifesciences Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Nectar Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Nectar Lifesciences Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

What is the latest dividend information for Nectar Lifesciences Ltd.?

Nectar Lifesciences Ltd. last declared a FINAL dividend of ₹ 0.05 per share for the financial period ending 2020. The record date was set as 2020-09-11, and the payment was/is scheduled around 2020-09-11. For the most current dividend announcements, refer to official company filings.